Insider · CIK 0001507174

LaBarre Michael J.

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001507174

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-27	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−1,597 sh	$58.25	−$93K	173,856
2025-02-27	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−100 sh	$58.74	−$5,874	173,756
2025-02-26	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−9,400 sh	$58.09	−$546K	176,053
2025-02-26	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−600 sh	$58.65	−$35.2K	175,453
2025-02-25	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−9,300 sh	$58.01	−$539K	186,153
2025-02-25	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−700 sh	$58.67	−$41.1K	185,453
2025-02-23	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+4,747 sh	—	—	197,863
2025-02-23	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, CHIEF TECHNICAL OFFICER	FTax Payment	−2,410 sh	$57.75	−$139K	195,453
2025-02-23	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−4,747 sh	—	—	14,238
2025-02-20	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	SVP, CHIEF TECHNICAL OFFICER	AAward	+11.9K sh	—	—	11,902
2025-02-20	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	SVP, CHIEF TECHNICAL OFFICER	AAward	+11.2K sh	—	—	11,230
2025-02-16	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+20.9K sh	—	—	196,729
2025-02-16	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, CHIEF TECHNICAL OFFICER	FTax Payment	−8,721 sh	$58.29	−$508K	188,008
2025-02-16	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+6,112 sh	—	—	194,120
2025-02-16	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, CHIEF TECHNICAL OFFICER	FTax Payment	−3,103 sh	$58.29	−$181K	191,017
2025-02-16	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+4,263 sh	—	—	195,280
2025-02-16	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, CHIEF TECHNICAL OFFICER	FTax Payment	−2,164 sh	$58.29	−$126K	193,116
2025-02-16	HALOHALOZYME THERAPEUTICS, INC. · Performance Stock UnitsM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−20.9K sh	—	—	0
2025-02-16	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−6,112 sh	—	—	6,112
2025-02-16	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−4,263 sh	—	—	8,526
2025-02-15	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+3,386 sh	—	—	177,142
2025-02-15	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, CHIEF TECHNICAL OFFICER	FTax Payment	−1,304 sh	$58.29	−$76K	175,838
2025-02-15	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−3,386 sh	—	—	0
2025-02-12	HALOHALOZYME THERAPEUTICS, INC. · Performance Stock UnitsA Award	SVP, CHIEF TECHNICAL OFFICER	AAward	+7,262 sh	—	—	20,891
2025-02-12	HALOHALOZYME THERAPEUTICS, INC. · Performance Stock UnitsA Award	SVP, CHIEF TECHNICAL OFFICER	AAward	+4,177 sh	—	—	6,547
2025-02-12	HALOHALOZYME THERAPEUTICS, INC. · Performance Stock UnitA Award	SVP, CHIEF TECHNICAL OFFICER	AAward	+4,921 sh	—	—	4,921
2025-02-12	HALOHALOZYME THERAPEUTICS, INC. · Performance Stock UnitsA Award	SVP, CHIEF TECHNICAL OFFICER	AAward	+20.3K sh	—	—	20,342
2024-10-16	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+10K sh	$19.98	+$200K	183,756
2024-10-16	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−10K sh	$53.26	−$533K	173,756
2024-10-16	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−10K sh	—	—	26,608
2024-10-15	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+5,509 sh	$16.65	+$91.7K	179,265
2024-10-15	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+4,491 sh	$19.98	+$89.7K	183,756
2024-10-15	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−9,923 sh	$53.74	−$533K	173,833
2024-10-15	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−77 sh	$54.24	−$4,176.865	173,756
2024-10-15	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−5,509 sh	—	—	6,352
2024-10-15	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−4,491 sh	—	—	36,608
2024-09-18	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+10K sh	$16.65	+$167K	183,756
2024-09-18	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−7,963 sh	$61.89	−$493K	175,793
2024-09-18	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−2,037 sh	$62.58	−$127K	173,756
2024-09-18	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−10K sh	—	—	11,861
2024-09-17	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+10K sh	$16.65	+$167K	183,756
2024-09-17	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−10K sh	$62.88	−$629K	173,756
2024-09-17	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−10K sh	—	—	21,861
2024-08-27	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+5,580 sh	$18.41	+$103K	173,756
2024-08-27	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−5,580 sh	—	—	0
2024-08-21	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+10K sh	$16.65	+$167K	178,176
2024-08-21	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−9,900 sh	$61.74	−$611K	168,276
2024-08-21	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF TECHNICAL OFFICER	SSale	−100 sh	$62.34	−$6,234	168,176
2024-08-21	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	−10K sh	—	—	31,861
2024-08-20	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF TECHNICAL OFFICER	MExercise/Conversion	+10K sh	$16.65	+$167K	178,176

Recent filings

Accepted (ET)
Feb 274
LaBarre Michael J.0001415889-25-005899
SEC(opens sec.gov)
Feb 244
LaBarre Michael J.0001415889-25-005311
SEC(opens sec.gov)
Feb 214
LaBarre Michael J.0001415889-25-005177
SEC(opens sec.gov)
Feb 184
LaBarre Michael J.0001415889-25-004509
SEC(opens sec.gov)

Companies

HALOZYME THERAPEUTICS, INC.SVP, CHIEF TECHNICAL OFFICERHALO

Address

11388 SORRENTO VALLEY ROAD

SAN DIEGO, CA, 92121